Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

Should we screen for lung cancer in Australia?

- Featured Image

Systematic screening reduces mortality, but is it the best way to go?

Lung cancer is the leading cause of cancer death in Australia. Late diagnosis of advanced disease contributes to the poor 13% 5-year survival rate associated with lung cancer. However, the recently updated United States National Lung Screening Trial (NLST) showed a 20% survival benefit from early detection with low-dose computed tomography (CT) screening.1,2 In light of these results, should people in Australia at high risk of lung cancer now undergo screening?

The NLST randomly allocated 53 000 participants to three rounds of annual screening with either chest CT or chest x-ray, with follow-up for a further 3 years.1,2 Unlike population-based screening programs for other common cancers, the NLST only enrolled high-risk participants (ie, current smokers or former smokers who had quit within the past 15 years, aged between 54 and 74 years, with > 30 pack-years). Adherence to screening was over 90%. At the initial screen, three times more stage…